Main Menu
Divisions
Public Inquiries (404) 639-3534 (800) 311-3435
Centers for Disease Control and Prevention 1600 Clifton Rd. Atlanta, GA 30333 U.S.A (404) 639-3311
Department of Health and Human Services - USA
HIV Spotlights
TB Spotlights
Updated Guidelines for the Use of Rifamycins for the Treatment of Tuberculosis Among HIV-Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors
MMWR Update: Adverse Event Data and Revised ATS/CDC Recommendations Against the Use of Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis Infection — United States, 2003
MMWR: Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection
Reported TB in the United States, 2001
TB Notes Newsletters
MMWR: Treatment of Tuberculosis (June 19, 2003)
Return to top of page
Privacy Policy Notice
About CDC | Announcements | Funding | Publications | Contact Us
CDC Home | Search | Health Topics A-Z
Last reviewed: October 04, 2004
United States Department of Health and Human Services First Gov Centers for Disease Control and Prevention NCHSTP 1108 Corporate Square, Atlanta, GA 30329 Phone: 404-639-8040 Please send comments/suggestions/requests to: nchstp@cdc.gov